The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/Neu-Driven Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-06-3867
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Down-Regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells

Anticancer Research
MedicineCancer ResearchOncology
2017English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

Regulation of the Tumor Suppressor Activity of P53 in Human Breast Cancer

2000English

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2003English

HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Inhibition of Cell Growth and Induction of Apoptosis byAntrodia Camphoratain HER-2/neu-Overexpressing Breast Cancer Cells Through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer

PLoS ONE
Multidisciplinary
2016English

Use of the Anti HER-2/neu Antibody Herceptin in the Treatment of Human Breast Cancer: Biological Rationale and Clinical Results

Breast Cancer Research
Cancer ResearchOncology
2000English

Lysyl Oxidase-Like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer

Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy